Report period | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
ALB:US | Albemarle Corporation | Common share | - | US0126531013 | $120.9 |
Company name | Albemarle |
---|---|
Tags | #dividend aristocrats, #s&p500 index, #renewable energy |
Sector | Materials / Materials / Chemicals / Specialty Chemicals |
Business address | 4350 CONGRESS STREET SUITE 700 CHARLOTTE NC 28209 980-299-5700 |
Mailing address | 4350 CONGRESS STREET SUITE 700 CHARLOTTE NC 28209 |
Website | www.albemarle.com |
Information disclosure | www.sec.gov |